These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 10780857)

  • 1. Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts.
    Woo JT; Kasai S; Stern PH; Nagai K
    J Bone Miner Res; 2000 Apr; 15(4):650-62. PubMed ID: 10780857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha).
    Woo JT; Nakagawa H; Krecic AM; Nagai K; Hamilton AD; Sebti SM; Stern PH
    Biochem Pharmacol; 2005 Jan; 69(1):87-95. PubMed ID: 15588717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
    Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH
    J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.
    Jimi E; Nakamura I; Duong LT; Ikebe T; Takahashi N; Rodan GA; Suda T
    Exp Cell Res; 1999 Feb; 247(1):84-93. PubMed ID: 10047450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.
    Lee MS; Kim HS; Yeon JT; Choi SW; Chun CH; Kwak HB; Oh J
    J Immunol; 2009 Sep; 183(5):3390-9. PubMed ID: 19641137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage colony-stimulating factor restores bone resorption in op/op bone in vitro in conjunction with parathyroid hormone or 1,25-dihydroxyvitamin D3.
    Morohashi T; Corboz VA; Fleisch H; Cecchini MG; Felix R
    J Bone Miner Res; 1994 Mar; 9(3):401-7. PubMed ID: 8191935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel synthetic triazolotriazepine derivative JTT-606 inhibits bone resorption by down-regulation of action and production of bone resorptive factors.
    Chikazu D; Shindo M; Iwasaka T; Katagiri M; Manabe N; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2000 Apr; 15(4):674-82. PubMed ID: 10780859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
    van't Hof RJ; Ralston SH
    J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
    Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
    J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
    Hughes A; Rogers MJ; Idris AI; Crockett JC
    Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of kampo formulae on bone resorption in vitro and in vivo. II. Detailed study of berberine.
    Li H; Miyahara T; Tezuka Y; Namba T; Suzuki T; Dowaki R; Watanabe M; Nemoto N; Tonami S; Seto H; Kadota S
    Biol Pharm Bull; 1999 Apr; 22(4):391-6. PubMed ID: 10328560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein tyrosine kinase inhibitors increase cytosolic calcium and inhibit actin organization as resorbing activity in rat osteoclasts.
    Kajiya H; Okabe K; Okamoto F; Tsuzuki T; Soeda H
    J Cell Physiol; 2000 Apr; 183(1):83-90. PubMed ID: 10699969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the role of cyclic AMP as a mediator of bone resorption: gamma-interferon completely inhibits cholera toxin- and forskolin-induced but only partially inhibits parathyroid hormone-stimulated 45Ca release from mouse calvarial bones.
    Lerner UH; Ransjö M; Ljunggren O; Klaushofer K; Hoffmann O; Peterlik M
    J Bone Miner Res; 1991 Jun; 6(6):551-60. PubMed ID: 1653515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
    Lerner UH
    J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of protease-activated receptor-2 leads to inhibition of osteoclast differentiation.
    Smith R; Ransjö M; Tatarczuch L; Song SJ; Pagel C; Morrison JR; Pike RN; Mackie EJ
    J Bone Miner Res; 2004 Mar; 19(3):507-16. PubMed ID: 15040840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins inhibit blastocyst formation by preventing geranylgeranylation.
    Alarcon VB; Marikawa Y
    Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone sensitizes long bones to the stimulation of bone resorption by 1,25-dihydroxyvitamin D3.
    van Leeuwen JP; Birkenhäger JC; Bos MP; van der Bemd GJ; Herrmann-Erlee MP; Pols HA
    J Bone Miner Res; 1992 Mar; 7(3):303-9. PubMed ID: 1585831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
    Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
    Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
    J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.